Bio-Path Ownership | Who Owns Bio-Path?
Bio-Path Ownership Summary
Bio-Path is owned by 0.44% institutional investors, 0.02% insiders, and 99.54% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.31% of its assets in Bio-Path shares.
BPTH Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Bio-Path | 0.44% | 0.02% | 99.54% |
| Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 1 | -95.24% | 31,127 | -90.24% | - | 0.25% | 1 | -91.67% | - | -100.00% |
| Dec 31, 2024 | 21 | 61.54% | 319,063 | 440.35% | 13 | 346.91% | 12 | 100.00% | 2 | - |
| Sep 30, 2024 | 13 | - | 59,048 | -58.60% | 1 | 2.50% | 6 | - | 2 | 100.00% |
| Jun 30, 2024 | 13 | 30.00% | 142,633 | 648.06% | 8 | 101.88% | 6 | - | 1 | -90.00% |
| Mar 31, 2024 | 10 | -50.00% | 19,067 | -96.81% | 2 | 12.63% | - | -100.00% | 10 | 400.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Institutional Extnd Mkt Idx Tr | 13.50K | 0.31% | - |
| Fidelity Extended Market Index | 11.96K | 0.21% | - |
| Fidelity Nasdaq Composite Index | 755.00 | 0.02% | - |
| NT Ext Equity Mkt Idx Fd - NL | 550.00 | 0.01% | - |
| NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 436.00 | 0.01% | -7.00 |
| Fidelity Series Total Market Index | 485.00 | 0.01% | - |
| NT Ext Equity Mkt Idx Fd - L | 305.00 | 0.01% | - |
| Northern Trust Extended Eq Market Idx | 305.00 | 0.01% | - |
| Spartan Extended Market Index Pool E | 225.00 | 0.01% | - |
| Fidelity Total Market Index | 170.00 | 0.00% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 18, 2019 | ARMISTICE CAPITAL, LLC | - | Sell | - |
| Jan 18, 2019 | ARMISTICE CAPITAL, LLC | - | Sell | $171.64K |
| Jul 13, 2015 | Garrison Michael J. | - | Buy | $8.96K |
| Jul 09, 2015 | Garrison Michael J. | - | Buy | $10.21K |
| Jul 08, 2015 | Garrison Michael J. | - | Buy | $25.22K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | - |
| 2023 Q2 | - | - |
| 2022 Q1 | - | - |
| 2021 Q1 | - | - |
| 2020 Q2 | - | - |
BPTH Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools